Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yavuz M Bilgin

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Blood Medicine|June 9, 2021
Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An UpdateYavuz M Bilgin
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Allogeneic leukocytes in cardiac surgery: Good or bad?Yavuz M Bilgin, Anneke Brand
Current Opinion in Hematology|November 12, 2015
Plerixafor for stem cell mobilization: the current statusYavuz M Bilgin, Georgine E de Greef
Cases Journal|October 16, 2009
An unusual presentation of a patient with intrathoracic stomach: a case reportYavuz M Bilgin, Hans E van der Wiel
Transfusion|January 16, 2008
Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusionsYavuz M Bilgin, Anneke Brand, Stefan P Berger, et al.
Critical Care Medicine|October 30, 2009
Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complicationsYavuz M Bilgin, Leo M G van de Watering, Michel I M Versteegh, et al.
Transfusion|June 8, 2011
Postoperative complications associated with transfusion of platelets and plasma in cardiac surgeryYavuz M Bilgin, Leo M G van de Watering, Michel I M Versteegh, et al.
Transfusion|February 3, 2015
Evaluation of Dutch guideline for just-in-time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte-colony-stimulating factorYavuz M Bilgin, Otto Visser, Erik A M Beckers, et al.
Blood|June 30, 2023
Risk of male breast cancer after Hodgkin lymphomaSimone de Vries, Inge M Krul, Michael Schaapveld, et al.
Blood Cancer Journal|May 22, 2023
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patientsA Vera de Jonge, Erik van Werkhoven, Avinash G Dinmohamed, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Blood Medicine|June 9, 2021
Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An UpdateYavuz M Bilgin
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Allogeneic leukocytes in cardiac surgery: Good or bad?Yavuz M Bilgin, Anneke Brand
Current Opinion in Hematology|November 12, 2015
Plerixafor for stem cell mobilization: the current statusYavuz M Bilgin, Georgine E de Greef
Cases Journal|October 16, 2009
An unusual presentation of a patient with intrathoracic stomach: a case reportYavuz M Bilgin, Hans E van der Wiel
Transfusion|January 16, 2008
Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusionsYavuz M Bilgin, Anneke Brand, Stefan P Berger, et al.
Critical Care Medicine|October 30, 2009
Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complicationsYavuz M Bilgin, Leo M G van de Watering, Michel I M Versteegh, et al.
Transfusion|June 8, 2011
Postoperative complications associated with transfusion of platelets and plasma in cardiac surgeryYavuz M Bilgin, Leo M G van de Watering, Michel I M Versteegh, et al.
Transfusion|February 3, 2015
Evaluation of Dutch guideline for just-in-time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte-colony-stimulating factorYavuz M Bilgin, Otto Visser, Erik A M Beckers, et al.
Blood|June 30, 2023
Risk of male breast cancer after Hodgkin lymphomaSimone de Vries, Inge M Krul, Michael Schaapveld, et al.
Blood Cancer Journal|May 22, 2023
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patientsA Vera de Jonge, Erik van Werkhoven, Avinash G Dinmohamed, et al.
Pageof 5